Our neuromodulation platform uses mechanical stimulation, not electrical stimulation - for drug-free pain relief. FDA 510K cleared to treat pain, our M-Stim(r) devices are used in over 6000 hospitals and clinics worldwide. CEO and Founder Dr. Amy Baxter pioneered M-stim to reduce procedural pain as an NIH researcher. In 2009 she created a neuromodulation platform starting with Buzzy® for needle pain. The award-winning device has blocked pain from over 114 million needle procedures and is used in homes, hospitals and labs in 28 countries. Home pain-treating products include cold/heat/vibration VibraCool devices for elbow, knee, neck, shoulder, ankle, and plantar fasciitis. New low back pain DuoTherm reduced pain 57% in the NIH-funded FastTrack pilot, with relief lasting 4 hours. The pivotal opioid use acute and chronic low back pain trials will be reported in 2024. The portable battery-powered focal muscle vibration (fMV) units are safe, easy to use, work on contact, and give hours relief. VibraCool ACL pilot showed 35% less opioid use than a coaching regimen. In a randomized crossover trial, PCL's VibraCool M-Stim unit alone showed 2-3.4x better PT pain relief than electrical stimulation. Our certified Women Owned Small Business stands behind our science, our mission, our values, and all our products.